<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Prajna R H</style></author><author><style face="normal" font="default" size="100%">Shivananda Nayak</style></author><author><style face="normal" font="default" size="100%">Priya V</style></author><author><style face="normal" font="default" size="100%">Shruthi Rai P</style></author><author><style face="normal" font="default" size="100%">Shivaraja shankara Y M</style></author><author><style face="normal" font="default" size="100%">Prashanthkumar Goudappala</style></author><author><style face="normal" font="default" size="100%">Dinesh PV</style></author><author><style face="normal" font="default" size="100%">Namratha KG</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The role of TNF-Alpha, IL-6, Adiponectin, and Leptin in Inflammation and Metabolic Dysregulation in Type 2 Diabetes Mellitus</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Adiponectin</style></keyword><keyword><style  face="normal" font="default" size="100%">IL-6</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Leptin</style></keyword><keyword><style  face="normal" font="default" size="100%">Metabolic Dysregulation</style></keyword><keyword><style  face="normal" font="default" size="100%">TNF-Alpha</style></keyword><keyword><style  face="normal" font="default" size="100%">Type 2 diabetes mellitus</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2025</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">699-702</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Type 2 Diabetes Mellitus (T2DM) is characterized by chronic inflammation and metabolic dysregulation. The present study investigates the role of inflammatory markers, including TNF-alpha and IL-6, and metabolic hormones such as adiponectin and leptin, in individuals with T2DM. &lt;strong&gt;Methods:&lt;/strong&gt; A total of 147 participants diagnosed with T2DM were included in the study. Clinical and biochemical parameters, including fasting blood sugar (FBS), glycated hemoglobin (HbA1C), adiponectin, leptin, TNF-alpha, and IL-6, were measured. Descriptive statistics and correlation analysis were performed to determine associations between inflammatory markers and metabolic dysregulation.&lt;strong&gt; Results: &lt;/strong&gt;The mean age of participants was &lt;strong&gt;42.63 ± 6.38 &lt;/strong&gt;years, and the average BMI was &lt;strong&gt;28.38 ± 2.25 kg/m²&lt;/strong&gt;. FBS and HbA1C levels were &lt;strong&gt;175.72 ± 61.61 mg/dL&lt;/strong&gt; and &lt;strong&gt;7.26 ± 0.94%,&lt;/strong&gt; respectively. The mean adiponectin and leptin levels were &lt;strong&gt;4.71 ± 1.75 μg/mL&lt;/strong&gt; and &lt;strong&gt;20.58 ± 5.19 ng/mL&lt;/strong&gt;, respectively. TNF-alpha and IL-6 levels averaged &lt;strong&gt;132.00 ± 9.45 pg/mL&lt;/strong&gt; and &lt;strong&gt;33.52 ± 14.55 pg/mL&lt;/strong&gt;, respectively. Correlation analysis indicated an inverse relationship between adiponectin and BMI, while leptin was positively correlated with BMI and insulin levels. Elevated TNFalpha and IL-6 levels were associated with increased HbA1C and fasting blood glucose. &lt;strong&gt;Conclusion: &lt;/strong&gt;This study highlights the significant role of inflammatory markers in metabolic dysregulation among T2DM patients. Elevated TNF-alpha and IL-6 levels reinforce the link between chronic inflammation and impaired glucose metabolism. These findings underscore the need for anti-inflammatory strategies in diabetes management.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">699</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Prajna R H&lt;sup&gt;1,2&lt;/sup&gt;, Shivananda Nayak&lt;sup&gt;3&lt;/sup&gt;, Priya V&lt;sup&gt;4*&lt;/sup&gt;, Shruthi Rai P&lt;sup&gt;5&lt;/sup&gt;, Shivaraja shankara Y M&lt;sup&gt;6&lt;/sup&gt;, Prashanthkumar Goudappala&lt;sup&gt;7&lt;/sup&gt;, Dinesh PV&lt;sup&gt;8&lt;/sup&gt;, Namratha KG&lt;sup&gt;9&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Research scholar, SaveethaResearch Center, Saveetha Institute of Medical and Technical Sciences(SIMATS), Chennai, INDIA,600077&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Assistant Professor, Department of Biochemistry, KVG Medical College and Hospital, Sullia, INDIA, 574327&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Professor, Department of Biochemistry, Subbaiah Institute of Medical Science, Shivamogga, INDIA,577222&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Professor, Center of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University Chennai, INDIA,600077&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Professor, Department of Biochemistry, KVG Medical College and Hospital, Sullia, INDIA, 574327&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Professor, Department of Biochemistry, KVG Medical College and Hospital, Sullia, INDIA, 574327&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;7&lt;/sup&gt;Associate Professor, Department of Biochemistry, Sri Siddhartha Medical College, Sri Siddhartha Academy of Higher Education, Tumkur, INDIA ,572107&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;8&lt;/sup&gt;Professor, Department of Community medicine, KVG Medical College and Hospital, Sullia, INDIA, 574327&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;9&lt;/sup&gt;Professor, Department of Microbiology, KVG Medical College and Hospital,Sullia , INDIA, 574327.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wardah Rahmatul Islamiyah</style></author><author><style face="normal" font="default" size="100%">Nasronudin</style></author><author><style face="normal" font="default" size="100%">Abdulloh Machin</style></author><author><style face="normal" font="default" size="100%">Iin Ernawati</style></author><author><style face="normal" font="default" size="100%">Yunita Dwi Tanti</style></author><author><style face="normal" font="default" size="100%">Nur Jaya</style></author><author><style face="normal" font="default" size="100%">Farah Medina</style></author><author><style face="normal" font="default" size="100%">Fathia Faza Rahmadanita</style></author><author><style face="normal" font="default" size="100%">Paulus Sugianto</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Analysis of The Effect of Leptin, AMPK, Adiponectin, and NPY Markers on Changes in Body Weight of Childhood Epileptic Using Valproic Acid Monotherapy</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Adiponectin</style></keyword><keyword><style  face="normal" font="default" size="100%">AMPK</style></keyword><keyword><style  face="normal" font="default" size="100%">Childhood.</style></keyword><keyword><style  face="normal" font="default" size="100%">Epilepsy</style></keyword><keyword><style  face="normal" font="default" size="100%">Leptin</style></keyword><keyword><style  face="normal" font="default" size="100%">NPY</style></keyword><keyword><style  face="normal" font="default" size="100%">Valproic acid</style></keyword><keyword><style  face="normal" font="default" size="100%">Weight gain</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">March 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">150-153</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction&lt;/strong&gt;: Epilepsy is a neurological disorder that occurs due to abnormal neurons in the brain and an imbalance between excitation and inhibition in the central nervous system. The first line of OAE in children is VPA (Valproate Acid). However, long-term use can cause weight gain with a frequency of 10-70%. The underlying mechanism of weight gain in patients remains unclear. &lt;strong&gt;Purpose: &lt;/strong&gt;This study aimed to analyze the relationship between levels of biomarkers AMPK, NPY, Leptin, and Adiponectin on changes in body weight in patients with epileptic seizures using VPA monotherapy. Method: This study is an observational cohort design. Data collection in April-June 2019. Inclusion criteria were children aged 2-10 years who used VPA requirement less than two years, not taking any drugs that affect body weight, not diagnose systemic lupus, nephrotic syndrome, and diabetes mellitus. Bodyweight and all biomarkers measurement on subjects who came to the clinic at the time of study and at least after one month of taking VPA. A total of 17 subjects participated in this study.&lt;strong&gt; Result: &lt;/strong&gt;The results of the statistical multivariate analysis test of VPA dosage on changes in body weight and biomarker levels found that Leptin, AMPK, Adiponectin did not significantly increase in body weight (p&amp;gt;0.05), but NPY significant increase in body weight (p&amp;lt;0.05). &lt;strong&gt;Conclusion:&lt;/strong&gt; NPY is the most potent for appetite enhancing, preferential effect on carbohydrate intake, weight regulation, energy storage, and expenditure. Increase production of NPY, there is an increase in energy intake and then increases fat storage and body weight.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">150</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Wardah Rahmatul Islamiyah1&lt;sup&gt;,2&lt;/sup&gt;, Nasronudin&lt;sup&gt;3,4,*&lt;/sup&gt;, Abdulloh Machin&lt;sup&gt;2&lt;/sup&gt;, Iin Ernawati&lt;sup&gt;5&lt;/sup&gt;, Yunita Dwi Tanti&lt;sup&gt;6&lt;/sup&gt;, Nur Jaya&lt;sup&gt;7&lt;/sup&gt;, Farah Medina&lt;sup&gt;8&lt;/sup&gt;, Fathia Faza Rahmadanita&lt;sup&gt;9&lt;/sup&gt;, Paulus Sugianto&lt;sup&gt;2&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Neurology, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Universitas Airlangga Hospital, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Departement of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Akademi Farmasi Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Ngudi Waluyo Hospital Wlingi Blitar, INDONESIA. 7Budi Agung Hospital, Palu, INDONESIA. 8Oncology Hospital, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;9&lt;/sup&gt;Faculty of Medicine and Health Science Maulana Malik Ibrahim State Islamic University Malang, Malang, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rani Wardani Hakim</style></author><author><style face="normal" font="default" size="100%">Fadilah Fadilah</style></author><author><style face="normal" font="default" size="100%">Tri Juli Edi Tarigan</style></author><author><style face="normal" font="default" size="100%">Sri Widia A Jusman</style></author><author><style face="normal" font="default" size="100%">Erni H Purwaningsih</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Molecular Study of Acalypha indica to Leptin, Alpha Glucosidase, and its Antihyperglycemic Effect on Alpha Glucosidase</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Acalypha indica</style></keyword><keyword><style  face="normal" font="default" size="100%">Alpha glucosidase.</style></keyword><keyword><style  face="normal" font="default" size="100%">Antiobesity</style></keyword><keyword><style  face="normal" font="default" size="100%">Leptin</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">1639-1647</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; The purpose of this study is to find potential inhibitors of leptin as a proinflammatory adipokine and alpha glucosidase as an enzyme that mediate hyperglycaemia; to alter the chronic complications of obesity from herbal Acalypha indica (Ai). This study was conducted using in silico molecular docking to evaluate the Ai compounds interaction with leptin and alpha glucosidase. The in vitro assay to alpha glucosidase was done to explore antihyperglycemic effect of Ai, as hyperglycaemia is the key process of chronic complication of obesity. &lt;strong&gt;Material and&lt;/strong&gt; &lt;strong&gt;Methods: &lt;/strong&gt;Protein target were leptin and alpha glucosidase; compounds from Ai plant were repundusinic, mauritanin, hesperetin, acaindinin, and glucogalin in pdb format. Molecular docking using autodock vinna. In vitro assay of Ai antihyperglycemic activity was done to alpha glucosidase and was define as IC50 level. &lt;strong&gt;Result:&lt;/strong&gt; The results from the docking analysis demonstrated that compounds from Ai roots contain antihyperglycemic-antiobesity activity which acted by inhibiting leptin and alpha glucosidase receptors. Repundusininc and mauritanin compounds contain hydrogen bond with the greatest leptin enhancer activity on Ser9, Thr35, Glu8, Ser9, Thr25, Gln111, Lys211, Leu7 for repundisinic and Glu8, Thr25, Gly112 and Leu7 for mauritanin. Hesperetin, acaindinin and glucogallin were the most identical compounds with similar affinity binding value to alpha glucosidase. Ai roots was already proven as anti-hyperglycemic-antiobesity which was further confirmed by in vitro assay to alpha glucosidase (IC50 19,429 μg/ml.). &lt;strong&gt;Conclusion:&lt;/strong&gt; The results demonstrated that Ai have anti hyperglycaemic-antiobesity effects and was found to be potentially as antihyperglycemic by in vitro assay to alpha glucosidase.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1639</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Rani Wardani Hakim&lt;sup&gt;1,2,6&lt;/sup&gt;,*, Fadilah Fadilah&lt;sup&gt;3,6,7&lt;/sup&gt;, Tri Juli Edi Tarigan&lt;sup&gt;4&lt;/sup&gt;, Sri Widia A Jusman&lt;sup&gt;5&lt;/sup&gt;, Erni H Purwaningsih&lt;sup&gt;2,6&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Doctoral Program in Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta 10430, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Medical Pharmacy, Faculty of Medicine, Universitas Indonesia, Jakarta 10430, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Medical Chemistry, Faculty of Medicine, Universitas Indonesia, Jakarta 10430, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Division of Endocrinology, Department of Internal Medicine, Dr. Cipto Mangunkusumo National Referral Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta 10430, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Department of Biochemistry and Molecular Biology, Faculty of Medicine, Universitas Indonesia, Jakarta 10430, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Drug Development and Research Cluster, The Indonesian Medical Education and Research Institute, Faculty of Medicine, University of Indonesia, Jakarta 10430, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;7&lt;/sup&gt;Bioinformatics Core Facilities, The Indonesian Medical Education and Research Institute, Faculty of Medicine, University of Indonesia, Jakarta 10430, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Iram Nazish</style></author><author><style face="normal" font="default" size="100%">S H Ansari</style></author><author><style face="normal" font="default" size="100%">Poonam Arora</style></author><author><style face="normal" font="default" size="100%">Adil Ahmad</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Antiobesity activity of Zingiber officinale</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">High-fat diet</style></keyword><keyword><style  face="normal" font="default" size="100%">Insulin.</style></keyword><keyword><style  face="normal" font="default" size="100%">Leptin</style></keyword><keyword><style  face="normal" font="default" size="100%">Rat</style></keyword><keyword><style  face="normal" font="default" size="100%">Zingiber officinale</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">Oct 2016</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">8</style></volume><pages><style face="normal" font="default" size="100%">440-446</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Context: &lt;/strong&gt;&lt;em&gt;Zingiber officinale&lt;/em&gt; Roscoe (Zingiberaceae) rhizome, known commonly as ginger is extensively used in Indian traditional system of medicine for treatment of various disorders. The ethanolic &lt;em&gt;Z. officinale&lt;/em&gt; extract is reported to have various activity such as antidiabetic, antihyperlipidemic and antioxidant activity in experimental animals. &lt;strong&gt;Objective:&lt;/strong&gt; To evaluate anti-obesity effect of aqueous &lt;em&gt;Z. officinale&lt;/em&gt; extract in murine model of high fat diet (HFD)- induced obesity. Materials and Methods: Male Wistar rats fed with HFD (20 g/day/rat, p.o) for a period of 42 days were used to induce obesity. Aqueous&lt;em&gt; Z. officinale&lt;/em&gt; extract (20 mg/kg b.w.) administered orally to HFD fed rats from day 8 to 50 days for a period of 42 days. Body weight gain, serum lipids, insulin and leptin parameters were measured. &lt;strong&gt;Results:&lt;/strong&gt; Oral feeding of the aqueous&lt;em&gt; Z. officinale&lt;/em&gt; extract (20 mg/kg) to HFD-induced obese rats for a period of 42 days resulted in significant reduction in body weight gain, insulin, leptin, lipids as compared to rats fed HFD alone. Further, the extract also showed significant increase in high density lipoprotein (HDL-C) levels.&lt;strong&gt; Discussion and Conclusion:&lt;/strong&gt; These results show that aqueous&lt;em&gt; Z. officinale&lt;/em&gt; extract possess significant anti-obesity potential.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">440</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Iram Nazish&lt;sup&gt;*1&lt;/sup&gt;, S H Ansari&lt;sup&gt;2&lt;/sup&gt;, Poonam Arora&lt;sup&gt;2&lt;/sup&gt;, Adil Ahmad&lt;sup&gt;2&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacology, HK College of Pharmacy, Oshiwara, Mumbai, INDIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Hamdard University, Hamdard Nagar, New Delhi, INDIA.&lt;/p&gt;
</style></auth-address></record></records></xml>